C. James Chou
Impact in
- Molecular Biology top 5%
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- Epigenetics and DNA Methylation
- Ubiquitin and proteasome pathways
- Psychiatry and Mental health top 2%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
Papers in
-
- Schizophrenia research and treatment 15
- Bipolar Disorder and Treatment 8
-
- Adenosine and Purinergic Signaling 5
- Co-authors
- Xiaoyang LiJesse J. McClureJoel GottesfeldElizabeth S. InksDavid HermanYingjie ZhangBenjamin J. JoseyPál Czobor
- Journals
- Journal of Medicinal Chemistry (12 papers)Bioorganic Chemistry (4 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)European Journal of Medicinal Chemistry (3 papers)Schizophrenia Bulletin (2 papers)
- Partner nations
- United StatesChinaJapan
In The Last Decade
C. James Chou
85 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 132
- Molecular Biology 2.1k
- Psychiatry and Mental health 460
- Toxicology 95
- Oncology 641
- Cellular and Molecular Neuroscience 394
Countries citing papers authored by C. James Chou
This map shows the geographic impact of C. James Chou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. James Chou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. James Chou more than expected).
Fields of papers citing papers by C. James Chou
This network shows the impact of papers produced by C. James Chou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. James Chou. The network helps show where C. James Chou may publish in the future.
Co-authors
The 25 scholars most cited alongside C. James Chou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 6 | |
| 5 | 2022 | 16 | |
| 6 | 2021 | 49 | |
| 7 | 2020 | 26 | |
| 8 | 2020 | 10 | |
| 9 | 2018 | 260 | |
| 10 | 2018 | 42 | |
| 11 | 2018 | 68 | |
| 12 | 2016 | 45 | |
| 13 | 2015 | 25 | |
| 14 | 2008 | 30 | |
| 15 | 2008 | 179 | |
| 16 | 2005 | 65 | |
| 17 | 2001 | 2 | |
| 18 | 2000 | 44 | |
| 19 | 1996 | 15 | |
| 20 | 1991 | 68 |
About C. James Chou
C. James Chou is a scholar working on Psychiatry and Mental health, Physiology, Molecular Biology, Oncology and Hematology, having authored 86 papers that have together received 3.5k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (42 papers), Protein Degradation and Inhibitors (22 papers), Peptidase Inhibition and Analysis (19 papers), Schizophrenia research and treatment (15 papers), Bipolar Disorder and Treatment (8 papers), Adenosine and Purinergic Signaling (5 papers), DNA and Nucleic Acid Chemistry (4 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers). The work is most often cited by research in Molecular Biology (2.1k citations), Psychiatry and Mental health (460 citations), Toxicology (95 citations), Oncology (641 citations) and Cellular and Molecular Neuroscience (394 citations). C. James Chou has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Xiaoyang Li, Jesse J. McClure, Joel Gottesfeld, Elizabeth S. Inks, David Herman, Yingjie Zhang, Benjamin J. Josey, Pál Czobor, Cheng Zhang and Wenfang Xu. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic Chemistry, Bioorganic & Medicinal Chemistry Letters, European Journal of Medicinal Chemistry and Schizophrenia Bulletin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.